Serotonin Modulates Fast-spiking Interneuron and Synchronous Activity in the Rat Prefrontal Cortex Through 5-HT1A and 5-HT2A Receptors

Overview

Journal J Neurosci

Specialty Neurology

Date 2010 Feb 12

PMID 20147548

Citations 98

Authors

M Victoria Puig

Akiya Watakabe

Mika Ushimaru

Tetsuo Yamamori

Yasuo Kawaguchi

Affiliations

Soon will be listed here.

Abstract

Alterations of the serotonergic system in the prefrontal cortex (PFC) are implicated in psychiatric disorders such as schizophrenia and depression. Although abnormal synchronous activity is observed in the PFC of these patients, little is known about the role of serotonin (5-HT) in cortical synchrony. We found that 5-HT, released by electrical stimulation of the dorsal raphe nucleus (DRN) in anesthetized rats, regulates the frequency and the amplitude of slow (<2 Hz) waves in the PFC via 5-HT(2A) receptors (5-HT(2A)Rs). 5-HT also modulates prefrontal gamma (30-80 Hz) rhythms through both 5-HT(1A)Rs and 5-HT(2A)Rs, but not 5-HT(2C)Rs, inducing an overall decrease in the amplitude of gamma oscillations. Because fast-spiking interneurons (FSi) are involved in the generation of gamma waves, we examined serotonergic modulation of FSi activity in vivo. Most FSi are inhibited by serotonin through 5-HT(1A)Rs, while a minority is activated by 5-HT(2A)Rs, and not 5-HT(2C)Rs. In situ hybridization histochemistry confirmed that distinct populations of FSi in the PFC express 5-HT(1A)Rs and 5-HT(2A)Rs, and that the number of FSi expressing 5-HT(2C)Rs is negligible. We conclude that 5-HT exerts a potent control on slow and gamma oscillations in the PFC. On the one hand, it shapes the frequency and amplitude of slow waves through 5-HT(2A)Rs. On the other hand, it finely tunes the amplitude of gamma oscillations through 5-HT(2A)R- and 5-HT(1A)R-expressing FSi, although it primarily downregulates gamma waves via the latter population. These results may provide insight into impaired serotonergic control of network activity in psychiatric illnesses such as schizophrenia and depression.

Citing Articles

Common and contrasting effects of 5-HTergic signaling in pyramidal cells and SOM interneurons of the mouse cortex.

Schmitz N, Hodzic S, Riedemann T Neuropsychopharmacology. 2024; .

PMID: 39511335 DOI: 10.1038/s41386-024-02022-x.

Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study.

Schwartzmann B, Chatterjee R, Vaghei Y, Quilty L, Allen T, Arnott S Transl Psychiatry. 2024; 14(1):432.

PMID: 39396045 PMC: 11470922. DOI: 10.1038/s41398-024-03110-8.

Decoupling of cortical activity from behavioral state following administration of the classic psychedelic DOI.

Olson R, Bartlett L, Sonneborn A, Milton R, Bretton-Granatoor Z, Firdous A Neuropharmacology. 2024; 257:110030.

PMID: 38851531 PMC: 11260522. DOI: 10.1016/j.neuropharm.2024.110030.

Optogenetic activation of dorsal raphe serotonin neurons induces brain-wide activation.

Hamada H, Abe Y, Takata N, Taira M, Tanaka K, Doya K Nat Commun. 2024; 15(1):4152.

PMID: 38755120 PMC: 11099070. DOI: 10.1038/s41467-024-48489-6.

Synthetic surprise as the foundation of the psychedelic experience.

De Filippo R, Schmitz D Neurosci Biobehav Rev. 2024; 157:105538.

PMID: 38220035 PMC: 10839673. DOI: 10.1016/j.neubiorev.2024.105538.

References

Harder J, Ridley R . The 5-HT1A antagonist, WAY 100 635, alleviates cognitive impairments induced by dizocilpine (MK-801) in monkeys. Neuropharmacology. 2000; 39(4):547-52. DOI: 10.1016/s0028-3908(99)00179-3. View

Aghajanian G, Marek G . Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res. 1999; 825(1-2):161-71. DOI: 10.1016/s0006-8993(99)01224-x. View

Jenck F, Moreau J, Mutel V, Martin J, HAEFELY W . Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol. 1993; 231(2):223-9. DOI: 10.1016/0014-2999(93)90453-o. View

Hoyer D . Molecular pharmacology and biology of 5-HT1C receptors. Trends Pharmacol Sci. 1988; 9(3):89-94. DOI: 10.1016/0165-6147(88)90174-5. View

Hajos M, Gartside S, Varga V, Sharp T . In vivo inhibition of neuronal activity in the rat ventromedial prefrontal cortex by midbrain-raphe nuclei: role of 5-HT1A receptors. Neuropharmacology. 2003; 45(1):72-81. DOI: 10.1016/s0028-3908(03)00139-4. View

Boothman L, Raley J, Denk F, Hirani E, Sharp T . In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Br J Pharmacol. 2006; 149(7):861-9. PMC: 2014685. DOI: 10.1038/sj.bjp.0706935. View

Lewis D, Hashimoto T, Volk D . Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 2005; 6(4):312-24. DOI: 10.1038/nrn1648. View

Robbins T . Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol. 2005; 493(1):140-6. DOI: 10.1002/cne.20717. View

Jakab R, Goldman-Rakic P . 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci U S A. 1998; 95(2):735-40. PMC: 18490. DOI: 10.1073/pnas.95.2.735. View

10.

Puig M, Celada P, Shapiro D, Roth B, Mengod G, Artigas F . Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci. 2001; 21(24):9856-66. PMC: 6763049. View

11.

Heisler L, Chu H, Brennan T, Danao J, Bajwa P, Parsons L . Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci U S A. 1998; 95(25):15049-54. PMC: 24573. DOI: 10.1073/pnas.95.25.15049. View

12.

Pinault D . A novel single-cell staining procedure performed in vivo under electrophysiological control: morpho-functional features of juxtacellularly labeled thalamic cells and other central neurons with biocytin or Neurobiotin. J Neurosci Methods. 1996; 65(2):113-36. DOI: 10.1016/0165-0270(95)00144-1. View

13.

Amargos-Bosch M, Bortolozzi A, Puig M, Serrats J, Adell A, Celada P . Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb Cortex. 2004; 14(3):281-99. DOI: 10.1093/cercor/bhg128. View

14.

De Almeida J, Mengod G . Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex. J Neurochem. 2007; 103(2):475-86. DOI: 10.1111/j.1471-4159.2007.04768.x. View

15.

DeFelipe J, Arellano J, Gomez A, Azmitia E, Munoz A . Pyramidal cell axons show a local specialization for GABA and 5-HT inputs in monkey and human cerebral cortex. J Comp Neurol. 2001; 433(1):148-55. DOI: 10.1002/cne.1132. View

16.

Celada P, Puig M, Diaz-Mataix L, Artigas F . The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs. Biol Psychiatry. 2008; 64(5):392-400. DOI: 10.1016/j.biopsych.2008.03.013. View

17.

Pompeiano M, Palacios J, Mengod G . Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res. 1994; 23(1-2):163-78. DOI: 10.1016/0169-328x(94)90223-2. View

18.

Bartos M, Vida I, Jonas P . Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci. 2006; 8(1):45-56. DOI: 10.1038/nrn2044. View

19.

Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F . Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex. 2004; 14(10):1100-9. DOI: 10.1093/cercor/bhh070. View

20.

Uematsu M, Hirai Y, Karube F, Ebihara S, Kato M, Abe K . Quantitative chemical composition of cortical GABAergic neurons revealed in transgenic venus-expressing rats. Cereb Cortex. 2007; 18(2):315-30. DOI: 10.1093/cercor/bhm056. View